EXHIBIT 8.1
Principal Subsidiaries
At 31 December 2005 | Country | Percentage of voting share capital held | Principal activity | ||||
UK | |||||||
AstraZeneca UK Limited | England | 1001 | Research and development, | ||||
manufacturing, marketing | |||||||
AstraZeneca Insurance Company Limited | England | 100 | Insurance and reinsurance | ||||
underwriting | |||||||
AstraZeneca Treasury Limited | England | 100 | Treasury | ||||
Continental Europe | |||||||
NV AstraZeneca SA | Belgium | 100 | Manufacturing, marketing | ||||
AstraZeneca Dunkerque Production SCS | France | 100 | Manufacturing | ||||
AstraZeneca SAS | France | 100 | Research, manufacturing, | ||||
marketing | |||||||
AstraZeneca GmbH | Germany | 100 | Development, manufacturing, | ||||
marketing | |||||||
AstraZeneca Holding GmbH | Germany | 100 | Manufacturing, marketing | ||||
AstraZeneca SpA | Italy | 100 | Manufacturing, marketing | ||||
AstraZeneca Farmaceutica Spain SA | Spain | 100 | Manufacturing, marketing | ||||
AstraZeneca AB | Sweden | 100 | Research and development, | ||||
manufacturing, marketing | |||||||
AstraZeneca BV | The Netherlands | 100 | Marketing | ||||
The Americas | |||||||
AstraZeneca Canada Inc. | Canada | 100 | Research, manufacturing, | ||||
marketing | |||||||
IPR Pharmaceuticals Inc. | Puerto Rico | 100 | Development, manufacturing, | ||||
marketing | |||||||
AstraZeneca LP | US | 99 | Research and development, | ||||
manufacturing, marketing | |||||||
AstraZeneca Pharmaceuticals LP | US | 100 | Research and development, | ||||
manufacturing, marketing | |||||||
Zeneca Holdings Inc. | US | 100 | Manufacturing, marketing | ||||
Asia, Africa & Australasia | |||||||
AstraZeneca Pty Limited | Australia | 100 | Development, manufacturing, | ||||
marketing | |||||||
AstraZeneca KK | Japan | 80 | Manufacturing, marketing | ||||
1 Shares held directly |